News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

United States Patent and Trademark Office Issues Cybergenetics' Patent for Andara(TM) OFS(TM) Therapy


4/11/2007 11:55:50 AM

FOXBOROUGH, Mass.--(BUSINESS WIRE)--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; Cyberkinetics), a neurotechnology company developing neurostimulation and neural sensing products designed to restore function, announced that it has been issued U.S. patent 7,199,110, entitled “Method of Treatment for Spinal Cord Injury,” by the United States Patent and Trademark Office. The patent relates to the Company’s Andara™ Oscillating Field Stimulator (OFS™) Therapy neural stimulation technology platform.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES